We are looking forward to our next on-site curATalks on May 15th. Our guests speakers will be Prof. Carolin Lerchenmüller and Ass. Prof. Marc Lerchenmüller. Carolin, who is Professor of Gender Medicine University of Zurich will give insights about her research in her talk “From Cardioprotection to Gender Medicine”. And Marc, who is Assistant Professor of Technological Innovation and Management at University of Mannheim will speak about „Bridging Discovery and Impact: The Role of the Science of Science in AdvancingTranslational Research“.

Recently, Carolin Lerchenmüller took over the newly established Chair of Gender Medicine and continues her clinical work in the Cardiology Department of the University Hospital Zurich. That is why she follows two research streams: One focuses on the protective effects of exercise on the heart, especially with respect to sex differences. She is also interested in better understanding past and present gaps in global research concerning Gender Medicine and the role of equity and diversity in medicine and science.

Marc Lerchenmüller is Assistant Professor of Technological Innovation and Management Science at the University of Mannheim and Research Fellow at the Centre for European Economic Research, a Leibniz Institute. His research focuses on the economics of innovation, in particular how incentives stimulate the creation and ultimately the application of scientific knowledge for the advancement of our societies.

Both curATalks will be held at the University Medical Center in Mainz, Building 708, seminar room 2 at 5 pm.

If you cannot join in person, you can also click here to join the virtual lecture.

curATime - Cluster for Atherothrombosis and Individualized Medicine - is our collaborative cluster for future which we initiated with the University Medical Center Mainz, the German Research Center for Artificial Intelligence (DFKI) and many more partners. The cluster is initially funded by the BMBF for three years. Within curATime, we want to reduce the incidence and impact of cardiovascular diseases, which is the leading cause of death worldwide.

Read more about curATime on www.curatime.org